Not a good buy right now for an impatient trader: trend is still bearish (SMA_200 > SMA_20 > SMA_5) and momentum is deteriorating (MACD histogram negative and expanding).
Price is sitting on/just above near-term support (S1 ~3.325). That can produce a short bounce, but there is no proprietary buy signal and options positioning is heavily defensive.
I would only turn constructive if GAIA reclaims the pivot (~3.55) and holds; until then, the higher-probability path is further chop/down toward ~3.19 (S2).
Momentum: MACD histogram -0.024 below zero and negatively expanding → selling pressure is increasing.
RSI: RSI_6 at 32.39 is near oversold territory; this supports the possibility of a reflex bounce, but it is not a reversal signal by itself.
Key levels: Immediate support S1 ~3.325 (price ~3.31 post-market is right at this area). Next support S2 ~3.185. Overhead pivot ~3.55 is the first meaningful reclaim level; resistances at ~3.775 (R1) and ~3.915 (R2).
Pattern-based forward drift (from similar candlesticks): mild bullish bias (+0.63% next day, +3.5% next week, +4.33% next month), but this conflicts with current bearish trend indicators—so follow-through is uncertain.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Put open interest 937 vs call open interest 146; OI put/call ratio 6.42 is strongly skewed to puts (defensive/bearish positioning).
Activity: Very low call volume (0) vs put volume (20); today’s volume is ~20.2x the 30-day average, suggesting a spike in attention, but it’s concentrated in puts.
Volatility: 30D IV ~133% vs historical vol ~49.6% with IV percentile ~77.7 → options are pricing an elevated move (often around events/uncertainty), which aligns with defensive put interest.
Takeaway: Options market tone is not confirming a confident upside entry right now; it looks more like hedging/speculating on downside into upcoming catalysts.
Technical Summary
Sell
9
Buy
4
Positive Catalysts
can produce a short-term rebound.
scheduled 2026-03-03 after hours; elevated IV suggests the market expects a sizable move into/around that event.
Neutral/Negative Catalysts
No supportive news flow in the last week; no positive narrative catalyst is currently visible.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: $24.984M, up 12.76% YoY (solid top-line growth).
Gross margin: 86.35%, up 0.41% YoY (very high margin profile, slightly improving).
Net income: -$1.153M, down -3.27% YoY (still unprofitable; losses not improving).
EPS: -$0.05, essentially flat YoY (no meaningful earnings momentum yet).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided in the dataset, so a recent trend summary cannot be confirmed.
Wall Street pros/cons view (inferred from available data only):
Pros: accelerating revenue growth and very high gross margins; insider buying is a meaningful positive.
Wall Street analysts forecast GAIA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GAIA is 7 USD with a low forecast of 7 USD and a high forecast of 7 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast GAIA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GAIA is 7 USD with a low forecast of 7 USD and a high forecast of 7 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.170
Low
7
Averages
7
High
7
Current: 3.170
Low
7
Averages
7
High
7
Roth Capital
Buy
downgrade
$8 -> $7
AI Analysis
2025-11-04
Reason
Roth Capital
Price Target
$8 -> $7
AI Analysis
2025-11-04
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Gaia to $7 from $8 and keeps a Buy rating on the shares after its Q3 results. The firm is lowering its forward estimates on slower SVOD and Igniton growth, noting that while the stock remains inexpensive, especially when factoring in Igniton, it may remain rangebound in the near-term until Igniton and AI licensing visibility improves, the analyst tells investors in a research note.